| Product |
CAS |
Molecular formula |
More |
| 1-((2-Bromopyridin-4-yl)methyl)piperidin-4-ol |
1420902-42-6 |
C11H15BrN2O |
More |
| (1-((2-Bromopyridin-4-yl)methyl)piperidin-2-yl)methanol |
1420986-15-7 |
C12H17BrN2O |
More |
| (1-((2-Bromopyridin-4-yl)methyl)piperidin-3-yl)methanol |
1420970-19-9 |
C12H17BrN2O |
More |
| (1-((2-Bromopyridin-4-yl)methyl)piperidin-4-yl)methanol |
1420809-54-6 |
C12H17BrN2O |
More |
| 1-((2-Bromopyridin-4-yl)methyl)pyrrolidin-3-ol |
1420970-27-9 |
C10H13BrN2O |
More |
| (S)-1-((2-bromopyridin-4-yl)methyl)pyrrolidin-3-ol |
1421046-77-6 |
C10H13BrN2O |
More |
| (R)-1-((2-bromopyridin-4-yl)methyl)pyrrolidin-3-ol |
1421042-08-1 |
C10H13BrN2O |
More |
| (1-((2-Bromopyridin-4-yl)methyl)pyrrolidin-2-yl)methanol |
1420804-23-4 |
C11H15BrN2O |
More |
| (1-((2-Bromopyridin-4-yl)methyl)pyrrolidin-3-yl)methanol |
1420986-26-0 |
C11H15BrN2O |
More |
| 1-((2-Bromopyridin-4-yl)methyl)-1,4-diazepane hydrochloride |
1420846-96-3 |
C11H17BrClN3 |
More |
| (1-((2-Bromopyridin-4-yl)methyl)azetidin-3-yl)methanol |
1420847-13-7 |
C10H13BrN2O |
More |
| Tert-butyl 4-((2-bromopyridin-4-yl)methyl)piperazine-1-carboxylate |
1350738-67-8 |
C15H22BrN3O2 |
More |
| Tert-butyl 4-((2-bromopyridin-4-yl)methyl)-2-methylpiperazine-1-carbox |
1420804-34-7 |
C16H24BrN3O2 |
More |
| Tert-butyl 4-((2-bromopyridin-4-yl)methyl)-3-methylpiperazine-1-carbox |
1420868-58-1 |
C16H24BrN3O2 |
More |
| (S)-tert-butyl 3-((5-methylpyridin-2-yl)oxy)piperidine-1-carboxylate |
1421012-95-4 |
C16H24N2O3 |
More |
| N1-((2-bromopyridin-4-yl)methyl)cyclohexane-1,4-diamine hydrochloride |
1420849-97-3 |
C12H19BrClN3 |
More |
| (1R,4r)-n1-((2-bromopyridin-4-yl)methyl)cyclohexane-1,4-diamine hydroc |
1420826-47-6 |
C12H19BrClN3 |
More |
| N1-((2-bromopyridin-4-yl)methyl)cyclohexane-1,2-diamine hydrochloride |
1420868-61-6 |
C12H19BrClN3 |
More |
| (1R,4r)-4-(((2-bromopyridin-4-yl)methyl)amino)cyclohexanol |
1420897-80-8 |
C12H17BrN2O |
More |
| (R)-tert-butyl 3-((5-methylpyridin-2-yl)oxy)piperidine-1-carboxylate |
1421012-41-0 |
C16H24N2O3 |
More |
